Results 111 to 120 of about 1,646,172 (334)

A review of the consensus conference on appropriate prosthetic technology in developing countries [PDF]

, 1996
H. JAMES DAY
openalex   +1 more source

Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

Kidney International, 2020
A. Levey, K. Eckardt, Nijsje M. Dorman, Stacy L. Christiansen, E. Hoorn, J. Ingelfinger, L. Inker, A. Levin, Rajnish Mehrotra, P. Palevsky, M. Perazella, A. Tong, Susan J. Allison, D. Bockenhauer, J. Briggs, J. Bromberg, A. Davenport, H. Feldman, D. Fouque, R. Gansevoort, J. Gill, E. Greene, B. Hemmelgarn, M. Kretzler, M. Lambie, P. Lane, J. Laycock, Shari Leventhal, M. Mittelman, Patricia Morrissey, M. Ostermann, L. Rees, P. Ronco, F. Schaefer, J. St Clair Russell, Caroline Vinck, S. Walsh, D. Weiner, Michael Cheung, M. Jadoul, W. Winkelmayer   +40 more
semanticscholar   +1 more source

Impact of Cytogenetic Response to Therapy on Long‐Term Survival in Acute Myeloid Leukemia

American Journal of Hematology, EarlyView.
ABSTRACT Prognostication in acute myeloid leukemia (AML) relies on clinical, molecular, and cytogenetic factors. In this retrospective study, we examined the impact of different levels of cytogenetic response on overall survival (OS) and event‐free survival (EFS) in AML.
John Hanna, Emily C. Zabor, Moath Albliwi, Jessica El‐Asmar, Daniel P. Nurse, Ameed Bawwab, Hasan Abuamsha, Yomna Abu‐Farsakh, Heya Batah, Asad Rauf, Joy Nakitandwe, David S. Bosler, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Ronald M. Sobecks, Anjali S. Advani, Hetty E. Carraway, Caroline Astbury, Moaath K. Mustafa Ali   +22 more
wiley   +1 more source

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report

American Journal of Hematology, EarlyView.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari, Raj S. Kasthuri, Hans‐Jurgen Mager, Jenny Y. Zhou, Marcelo M. Serra, Bethany T. Samuelson‐Bannow, Layla N. Van Doren, Jay F. Piccirillo, Marianne S. Clancy, Keith R. McCrae, Sonia M. Thomas, Antoni Riera‐Mestre, Allyson M. Pishko, Sarah Sewaralthahab, James R. Gossage, Vivek N. Iyer, Cedric Hermans, Adrienne Hammill, Ingrid Winship, Meir Mei‐Zahav, Annette von Drygalski, Scott Olitsky, Marie E. Faughnan   +22 more
wiley   +1 more source

Dentofacial Malocclusion in Neurofibromatosis 1 in Finland

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Neurofibromatosis 1 (NF1) is an inherited disease that can be accompanied by oral health problems such as caries, periodontitis, and tumors affecting the oral cavity. Also, different maxillary and mandibular malformations are associated with NF1.
Vivian Reinhold, Mikko Valtanen, Kari Auranen, Stina Syrjänen, Sirkku Peltonen, Juha Peltonen, Roope A. Kallionpää   +6 more
wiley   +1 more source

In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions

European Urology Open Science, 2021
Rapid innovations for treatment and diagnostic procedures in advanced prostate cancer have led to improved outcomes, although uncertainty remains regarding the best management approach in many clinical situations.
Manolis Pratsinis, Susan Halabi, Sabine Güsewell, Silke Gillessen, Aurelius Omlin   +4 more
doaj  

Parental Communication With their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and Counseling

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Cascade genetic testing for cancer risk can influence relatives' health outcomes, as they may benefit from risk reduction and screening. However, clinical guidelines discourage predictive genetic testing in childhood—including direct‐to‐consumer (DTC) testing.
Marcelo M. Sleiman Jr., Talia Zamir, Beth N. Peshkin, Jada G. Hamilton, Mingqian Liu, Mary Rose Yockel, Benjamin Wilfond, Lainie Friedman Ross, Jamie Brower, Hannah Ovadia, Rosalba Sacca, Beth Tarini, Susan M. Domchek, Claudine Isaacs, Kenneth P. Tercyak   +14 more
wiley   +1 more source

National Institutes of Health Consensus Development Conference Statement on Genetictesting for Cystic Fibrosis [PDF]

, 1997
Richard A. Doherty
openalex   +1 more source

Perspectives on the Current and Future State of Artificial Intelligence in Medical Genetics

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Artificial intelligence (AI) is rapidly transforming numerous aspects of daily life, including clinical practice and biomedical research. In light of this rapid transformation, and in the context of medical genetics, we assembled a group of leaders in the field to respond to the question about how AI is affecting, and especially how AI will ...
Benjamin D. Solomon, Morgan Cheatham, Thales A. C. de Guimarães, Dat Duong, Melissa A. Haendel, Tzung‐Chien Hsieh, Behnam Javanmardi, Britt Johnson, Peter Krawitz, Paul Kruszka, Tim Laurent, Ni‐Chung Lee, Kirsty McWalter, Michel Michaelides, Klaus Mohnike, Nikolas Pontikos, Maria J. Guillen Sacoto, Yousif J. Shwetar, Vincent D. Ustach, Rebekah L. Waikel, William Woof   +20 more
wiley   +1 more source

Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia [PDF]

, 1998
Alejandro Ruiz-Arg�elles, Ricardo E. Duque, Alberto Órfão   +2 more
openalex   +1 more source